KEUTZER TIMOTHY (Chief Development Officer) sold 7.1% of their position (56.54K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $44.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/5/2025ACC: 0000950170-25-014866
Officer· Chief Development Officer
Since Jan 2020
+209.60K
Net shares
Net buyer
$44.1K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
266.14K acquired · 56.54K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+266.14K
Price / share
—
Trade value
—
% of position
50.0%
2/3/2025
531.84K→797.98K
Common Stock
Direct
Shares
−3.97K
Price / share
$0.78
Trade value
$3.10K
% of position
0.5%
2/5/2025
797.98K→794K
Common Stock
Direct
Shares
−27.64K
Price / share
$0.78
Trade value
$21.56K
% of position
3.5%
2/5/2025
794K→766.36K
Common Stock
Direct
Shares
−24.92K
Price / share
$0.78
Trade value
$19.44K
% of position
3.3%
2/5/2025
766.36K→741.44K
Total
Net shares
+209.60K
Net value
-$44.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | A · Award | +266.14K | — | — | 50.0% | 531.84K | 797.98K |
| Common Stock Direct | 2/5/2025 | S · Sale | −3.97K | $0.78 | $3.10K | 0.5% | 797.98K | 794K |
| Common Stock Direct | 2/5/2025 | S · Sale | −27.64K | $0.78 | $21.56K | 3.5% | 794K | 766.36K |
| Common Stock Direct | 2/5/2025 | S · Sale | −24.92K | $0.78 | $19.44K | 3.3% | 766.36K | 741.44K |
| Total | +209.60K | -$44.10K | ||||||
Derivative Transactions0
No derivative transactions reported